Select your cookie preferences

We use essential cookies and similar tools that are necessary to provide our site and services. We use performance cookies to collect anonymous statistics, so we can understand how customers use our site and make improvements. Essential cookies cannot be deactivated, but you can choose “Customize” or “Decline” to decline performance cookies.

If you agree, AWS and approved third parties will also use cookies to provide useful site features, remember your preferences, and display relevant content, including relevant advertising. To accept or decline all non-essential cookies, choose “Accept” or “Decline.” To make more detailed choices, choose “Customize.”

Sign in
Your Saved List Become a Channel Partner Sell in AWS Marketplace Amazon Web Services Home Help

truly accessible automation

  • By Hospital & Health Care
  • on 12/16/2024

What do you like best about the product?
Tines has made it easy to automate tasks to ensure they are done in reliable and repeatable ways with simple API integrations. I have used Tines to automate countless tasks from enriching information to eliminating manual ticketing processes. Tines allows me to ensure that people are doing valuable work. The thing that makes Tines unique is its community mindset, and the desire of that community to share ideas.
What do you dislike about the product?
I frankly can't think of anything I dislike about Tines because I have not yet found something that I could not automate with it.
What problems is the product solving and how is that benefiting you?
Tines allows us to eliminate fragile manual tasks to ensure they are done consistent and measurable ways. We use it for ticket encrichment, employee self-service of takss like checking compliance training status, understanding whether traffic is being blocked, submitting infrastructure as code changes through forms, to risk register entry creation. The opportuntiies for automation through Tines are limited by your imagination and the number of stories you are licensed for.


There are no comments to display